One recent study assessed occurrence of hepatocellular carcinoma in patients with hepatitis C-associated cirrhosis, while another looked at the effect of hepatobiliary cancer surveillance on outcomes in patients with primary sclerosing cholangitis.
A double-blind trial compared the effectiveness of tenofovir disoproxil fumarate versus placebo for prevention of perinatal transmission of hepatitis B virus (HBV), while another study examined postpartum disease flares of treatment-naïve mothers
One recent study looked at whether NSAID use was linked to incident pancreatic adenocarcinoma, while the other examined acetaminophen-induced hepatotoxicity.
One recent study found a threefold increase in mortality among patients with childhood-onset inflammatory bowel disease (IBD) compared to individuals without the disease, while another found that patients with IBD have a higher risk of certain
New diagnoses of colorectal cancer plummeted at the start of the COVID-19 pandemic, and diagnosis and management were also the focus of recent research and a clinical practice update from the American Gastroenterological Association.
One study found that colorectal cancer diagnosed six to 60 months after colonoscopy leads to a shorter life expectancy, while two others found increased risks of mental illness and chronic opioid use among colorectal cancer survivors.
Highlights from the conference, held this past week in San Diego, included new research and clinical tips on stopping Barrett's esophagus surveillance, diet and environmental risk factors in patients with inflammatory bowel disease, and new research
Recent studies came to differing conclusions in their assessments of the safety of proton-pump inhibitors (PPIs), with outcomes including mortality, hepatic encephalopathy, and infections.
In the past month, the U.S. Preventive Services Task Force published a draft recommendation statement on screening for hepatitis B virus (HBV) infection, and two systematic reviews and meta-analyses looked at treatments and a novel immunoassay to
Recent research has found that patients with inflammatory bowel disease (IBD) may have increased risk of Parkinson's disease and that this risk may be modified by anti-tumor necrosis factor therapy.